Federal regulators shook up the booming weight loss drug marketplace when they announced Mounjaro and Zepbound to be no ...
The U.S. Food and Drug Administration on Friday agreed to reconsider its recent decision barring drug compounders from ...
Some patients fear that they’ll lose access to tirzepatide because the US Food and Drug Administration determined that a ...
Eli Lilly (LLY) is calling on companies that have been selling off-brand versions of its popular diabetes and weight-loss ...
With the resolution, compounding pharmacies are no longer able to produce tirzepatide. And the FDA highlighted the point to ...
Poor purity can cause patients to experience fever, chills, nausea, skin irritation, infections and low blood pressure.
Only a fifth of large U.S. companies cover pricey GLP-1 weight-loss drugs like Wegovy and Zepbound in their health insurance ...
Key Takeaways Shares of WW International, better known as WeightWatchers, soared Tuesday after it said it is offering copycat ...
Just like when you find a glitzy resort in your dream destination, your first question about weight loss drugs might be, how ...
There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.
The FDA has decided to reconsider its previous decision that barred drug compounders from selling their versions of Eli Lilly ...
Click in for more news from The Hill{beacon} Health Care Health Care   The Big Story Rival manufacturers fight for the right to sell weight loss drugsThere’s a new fight brewing between ...